Health

Results: 433-444 of 8091

Bial Achieves Key Milestone in Phase 2b ACTIVATE Study of BIA 28-6156 in GBA1-Associated Parkinson’s Disease

PR Newswire associated0

Boehringer Ingelheim and Simcere partner to advance a dual-target antibody treatment to address unmet needs in inflammatory bowel disease

BIOSeedin Winter Innovation Partnering Summit: J.P.Morgan Spotlight

Asthma and Allergy Drug Development Is Failing Too Often--A Translational Reset Is Needed: HKEY-AIRx™1.0

PR Newswire associated0

Servier delivers solid performance in 2024/25 and confirms its forecasts for 2030

3Shape appoints Rasmus Hannemann as Senior Vice President, Portfolio & Product Strategy

PR Newswire associated0

The European Commission extended the Marketing Authorisation for Vueway® (gadopiclenol) in the European Union for use in pediatric patients under 2 years of age

The European Investment Bank (EIB) provides €20 million in financing to SamanTree Medical, a leader in surgical imaging innovation. The financing supports the development of an advanced confocal microscopy scanner for rapid imaging of the internal microstructure of tissue samples during surgical procedures, R&D and continued development and advancement of the company's Histolog® Scanner, the first and only medical imaging device featuring massively parallel confocal microscopy. Shown: Alessandro Izzo, EIB Director (left) and Olivier Delporte, CEO of SamanTree Medical (right).

EIB Provides €20 Million in Financing to SamanTree Medical for Real-Time Microscopy for Surgical Procedures

PR Newswire associated0

ICP DAS-BMP at WHX Dubai 2026 Spotlights Low-Migration and Low-Friction TPU

Eisai submits Marketing Authorisation Variation to EMA for intravenous maintenance dosing every four weeks with Leqembi® (lecanemab)

Change of date for publication of the year-end report for the financial year 2025

PR Newswire associated0

First Patient Treated in Myra Vision's U.S. ADAPT Clinical Study for Glaucoma